SCHEMBL10239398

SCHEMBL10239398

[2H]C(C(=O)OCC)C1([2H])CCC(c2cc(N(COCC[Si](C)(C)C)COCC[Si](C)(C)C)n3ncc(-c4cnc5ccccc5c4)c3n2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.35
DGAT1 O75907 3/20 0.35
MTOR P42345 3/20 0.34
AKT1 P31749 2/20 0.34
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HSD17B10 Q99714 2/20 0.32
CHEK1 O14757 1/20 0.32
MAT2A P31153 1/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
MAPK1 P28482 1/20 0.31
NPC1 O15118 1/20 0.30
TP53 P04637 1/20 0.30
NFKB1 P19838 1/20 0.30
STAT1 P42224 1/20 0.30
RAB9A P51151 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL595034 0.90 DGAT1 (0.41) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL10239403 0.89 DGAT1 (0.37) PIK3CADGAT1KDM4EL3MBTL1HSD17B10
SCHEMBL10239396 0.87 PIK3CA (0.34) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL2679762 0.85 DGAT1 (0.35) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL2679335 0.85 DGAT1 (0.37) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL10236654 0.85 DGAT1 (0.37) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL10239397 0.85 KDM4E (0.38) DGAT1KDM4EHSD17B10
SCHEMBL2679521 0.84 SMO (0.37) PIK3CAMTORAKT1TP53
SCHEMBL616886 0.83 MAT2A (0.34) PIK3CADGAT1MTORAKT1KDM4E
SCHEMBL10328253 0.83 KDM4E (0.37) DGAT1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MTOR, RICTOR, RPTOR PIK3CA 34/4885DGAT1 3031/4885MTOR 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.